.AstraZeneca has actually shared an early look at the functionality of its own in-house antibody-dru...
.After introducing a period 3 launch based upon favorable midstage outcomes, iTeos and GSK are actua...
.The FDA ought to be actually more open as well as collaborative to unleash a surge in commendations...
.It's an uncommonly hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara ...
.Atea Pharmaceuticals' antiviral has actually fallen short one more COVID-19 trial, yet the biotech ...
.Neurocrine Biosciences' mental illness plan pivot has actually stopped working. The biotech was act...
.Sanofi has actually brought in a late entry to the radioligand gathering, paying for 100 thousand e...
.After F2G's 1st effort to acquire a new training class of antifungal to market was actually deraile...
.Moderna has promised to cut R&D investing through $1.1 billion through 2027. The choice to retra...
.Only four months after Sanofi wager $80 million in ahead of time money on Pivot Therapies' losmapim...